Literature DB >> 31040186

Mortality Risk in IgA Nephropathy.

Richard J Glassock1.   

Abstract

Entities:  

Keywords:  End Stage Kidney Disease risk; IgA nephropathy; mortality risk

Mesh：

Year:  2019        PMID： 31040186      PMCID： PMC6493985          DOI： 10.1681/ASN.2018121255

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  11 in total

Review 1.  Immortal time bias in pharmaco-epidemiology.

Authors:  Samy Suissa
Journal:  Am J Epidemiol       Date:  2007-12-03       Impact factor: 4.897

Review 2.  IgA Nephropathy.

Authors:  Jennifer C Rodrigues; Mark Haas; Heather N Reich
Journal:  Clin J Am Soc Nephrol       Date:  2017-02-03       Impact factor: 8.237

3.  The CKD Classification System in the Precision Medicine Era.

Authors:  Yoshio N Hall; Jonathan Himmelfarb
Journal:  Clin J Am Soc Nephrol       Date:  2016-11-30       Impact factor: 8.237

4.  Mortality in patients with IgA nephropathy.

Authors:  Thomas Knoop; Bjørn Egil Vikse; Einar Svarstad; Sabine Leh; Anna Varberg Reisæter; Rune Bjørneklett
Journal:  Am J Kidney Dis       Date:  2013-06-21       Impact factor: 8.860

5.  Epidemiology of IgA Nephropathy: A Global Perspective.

Authors:  Francesco Paolo Schena; Ionut Nistor
Journal:  Semin Nephrol       Date:  2018-09       Impact factor: 5.299

Review 6.  IgA nephropathy.

Authors:  Kar Neng Lai; Sydney C W Tang; Francesco Paolo Schena; Jan Novak; Yasuhiko Tomino; Agnes B Fogo; Richard J Glassock
Journal:  Nat Rev Dis Primers       Date:  2016-02-11       Impact factor: 52.329

7.  Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial.

Authors:  Jicheng Lv; Hong Zhang; Muh Geot Wong; Meg J Jardine; Michelle Hladunewich; Vivek Jha; Helen Monaghan; Minghui Zhao; Sean Barbour; Heather Reich; Daniel Cattran; Richard Glassock; Adeera Levin; David Wheeler; Mark Woodward; Laurent Billot; Tak Mao Chan; Zhi-Hong Liu; David W Johnson; Alan Cass; John Feehally; Jürgen Floege; Giuseppe Remuzzi; Yangfeng Wu; Rajiv Agarwal; Hai-Yan Wang; Vlado Perkovic
Journal:  JAMA       Date:  2017-08-01       Impact factor: 56.272

8.  A scoring system to predict renal outcome in IgA nephropathy: a nationwide 10-year prospective cohort study.

Authors:  Masashi Goto; Kenji Wakai; Takashi Kawamura; Masahiko Ando; Masayuki Endoh; Yasuhiko Tomino
Journal:  Nephrol Dial Transplant       Date:  2009-06-10       Impact factor: 5.992

9.  Age and association of kidney measures with mortality and end-stage renal disease.

Authors:  Stein I Hallan; Kunihiro Matsushita; Yingying Sang; Bakhtawar K Mahmoodi; Corri Black; Areef Ishani; Nanne Kleefstra; David Naimark; Paul Roderick; Marcello Tonelli; Jack F M Wetzels; Brad C Astor; Ron T Gansevoort; Adeera Levin; Chi-Pang Wen; Josef Coresh
Journal:  JAMA       Date:  2012-12-12       Impact factor: 56.272

10.  Mortality of IgA nephropathy patients: a single center experience over 30 years.

Authors:  Hajeong Lee; Dong Ki Kim; Kook-Hwan Oh; Kwon Wook Joo; Yon Su Kim; Dong-Wan Chae; Suhnggwon Kim; Ho Jun Chin
Journal:  PLoS One       Date:  2012-12-04       Impact factor: 3.240
View more
  1 in total

Review 1.  Efficacy and Safety of Renin-Angiotensin Aldosterone System Inhibitor in Patients with IgA Nephropathy: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Yu Zhao; Heng Fan; Bei-Yan Bao
Journal:  Iran J Public Health       Date:  2019-09       Impact factor: 1.429
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.